India has roughly 2.4 million people living with HIV, the third-largest population in the world, and about 40 percent of them are women — most of working and reproductive age. That means HIV in pregnancy is not a rare clinical curiosity in India; it is a regular part of antenatal care, and the public system is set up for it.

Without any treatment, an HIV-positive mother passes the virus to her baby in roughly 25 to 40 percent of pregnancies, counting transmission in the womb, during labour and through breastfeeding. With full PMTCT — Prevention of Mother-to-Child Transmission — that figure drops to under 1 percent. The intervention is not exotic. It is one tablet a day for the mother, careful timing around delivery, six weeks of syrup for the baby, and follow-up tests at fixed intervals. All of it is free in the government system through ART centres and Integrated Counselling and Testing Centres (ICTCs).

The same care that protects the baby also keeps the mother well. ART is not stopped after delivery — it is continued for life, because HIV is a chronic infection and treatment is what keeps it suppressed. So this is not a sacrifice the mother makes for the pregnancy; it is the same medication she would be taking outside pregnancy, just started or continued through it. If you are reading this around a recent diagnosis, the most important early step is the same as any new pregnancy — see is my body ready to conceive for the wider preconception picture, layered with HIV-specific planning.

The National AIDS Control Organisation runs a country-wide PMTCT programme through ICTCs at every community health centre and primary health centre, with ART delivered through ART centres at district and tertiary hospitals. The full pathway is offered free, including the medication, the laboratory tests and the counselling sessions.

HIV testing is offered at the very first antenatal visit and again at 28 weeks, with an option for a rapid test in labour if the earlier results are not available or if there has been a possible exposure since. Testing is opt-out — meaning it is part of the standard booking bloods unless the woman declines — which has made detection rates much higher than the older opt-in model. The partner is offered free testing too, and is started on either ART (if positive) or PrEP (in some settings, if negative and the woman is positive).

If the result is positive, antiretroviral therapy is started the same day in most centres, regardless of CD4 count or pregnancy week. The first-line regimen across India is a single combined tablet of tenofovir, lamivudine and dolutegravir (TLD), taken once a day, lifelong. Older drugs are now used only in specific situations. Hospital delivery is strongly recommended over home delivery, the baby is given nevirapine syrup for 6 weeks, and the baby is tested at fixed intervals to confirm HIV status. Every step of that ladder is what takes vertical transmission below 1 percent.

Antenatal care looks almost the same as in any pregnancy — weight, blood pressure, fundal height, fetal heart rate, the dating scan, the anomaly scan, growth scans, iron and folic acid, calcium, tetanus boosters, the influenza vaccine if available, and the standard schedule of visits. None of those routine elements are skipped because of HIV; if anything, the visit cadence is a little tighter.

The HIV-specific layer on top is mostly two tests — CD4 count and viral load — done at the booking visit, in the second trimester, and again at around 34 to 36 weeks. The viral load result near term is the single most important number for delivery planning. The goal across the pregnancy is an undetectable viral load before labour starts. ART is continued without interruption; the TLD regimen has been used safely across all trimesters in pregnancy.

Mental health is part of antenatal care too, and in an HIV-positive pregnancy it carries an extra weight — fear of disclosure, anxiety about the baby's result, the loneliness of carrying a diagnosis that still gets met with judgement. ICTC counsellors are trained for this, and many ART centres run support groups. For how a routine Indian scan and lab report is read, including how viral load and CD4 fit alongside the obstetric numbers, see understanding scans labs reports.

The mode of delivery in an HIV-positive pregnancy is decided largely by the viral load result near term, not by HIV status itself. The blanket old advice that every HIV-positive mother should have a caesarean section is outdated.

If the viral load at 34 to 36 weeks is undetectable, vaginal delivery is safe and is the standard recommendation. A few practical adjustments are made during labour to reduce any small residual risk: prolonged rupture of membranes is avoided where possible, fetal scalp electrodes and fetal scalp sampling are not used, instrumental delivery (forceps or vacuum) is reserved for clear indications rather than chosen routinely, and episiotomy is performed only when truly needed. The mother continues her ART through labour.

If the viral load is detectable near term — or if it has not been checked late in pregnancy — an elective caesarean section at 38 weeks plus intravenous zidovudine in labour is offered, because both interventions further reduce the chance of passing HIV during birth. The caesarean is otherwise identical to any planned section: spinal anaesthesia, skin-to-skin contact in theatre or recovery, and the same recovery course. Either way, hospital delivery is strongly preferred over a home birth, both for monitoring during labour and for the baby's first dose of nevirapine.

For the mother, ART continues exactly as before — the same single TLD tablet, once a day, lifelong. There is no change in dose, no plan to taper after delivery, and no break for breastfeeding. The same ICTC and ART centre supplies the medication for free.

The baby starts nevirapine syrup within the first 6 to 12 hours of birth and continues it for 6 weeks. If the mother's viral load is high near delivery, this is sometimes extended to 12 weeks at the doctor's discretion. The syrup is given by mouth, the dose is weight-based, and it is one of the simplest medication regimens in newborn care.

Postnatal contraception is discussed early, often before discharge — both because pregnancies very close together carry their own risks and because contraceptive choices interact with ART differently. DMPA injections, copper IUDs, and the lactational amenorrhoea method are commonly used; combined oral contraceptives need a small check for interactions with the specific ART regimen.

Postpartum mental health is followed actively, not just asked about once. Many women report the relief of a negative early baby PCR as a major emotional shift; others carry the weight of disclosure decisions, relationship dynamics, in-law pressure or the fear of someone finding out at work. None of that is unusual, and none of it is a personal failing — it is the predictable aftermath of carrying a stigmatised diagnosis through a major life event.

In high-income countries with reliable clean water, refrigeration and continuous formula supply, exclusive formula feeding has historically been recommended for HIV-positive mothers to eliminate any milk-borne transmission. In India, the calculation is different and NACO recommends exclusive breastfeeding for the first six months alongside maternal ART — because the risk of diarrhoeal disease, malnutrition and death from unsafe formula preparation is, for most Indian households, higher than the residual transmission risk when the mother is on consistent ART.

With maternal ART maintained throughout breastfeeding, the transmission risk through breastmilk is below 1 percent. The two non-negotiable conditions for this to hold are exclusive breastfeeding — meaning no mixed feeding with formula, water or other liquids in the first six months, because mixed feeding raises transmission risk — and tight ART adherence with no missed doses. After six months, complementary foods are added as in any baby, and breastfeeding can continue alongside, with the baby still on routine follow-up testing.

Formula feeding is the right choice for some families — typically when clean water, fuel for boiling, refrigeration and a continuous supply of formula are all reliably available, and the family can commit to exclusive formula feeding without mixing. In that case, the baby is not breastfed at all, even briefly. The middle path of mixed feeding is the one to actively avoid, because it combines the highest risks of both routes.

Stigma is still the hardest part of an HIV-positive pregnancy in India for many women — harder than the medication, the tests or the delivery decisions. Some of it is internal, carried as guilt or fear; much of it is external, in extended families, neighbourhoods, workplaces and even occasionally in healthcare settings that should know better.

Disclosure to a partner, family or employer is the woman's own decision. The law does not require an HIV-positive woman to disclose to her employer; it does not require disclosure to extended family; and a healthcare provider who shares an HIV status without consent is breaching the HIV and AIDS (Prevention and Control) Act, 2017. Disclosure to a sexual partner sits in a more nuanced space — many women find that early, supported disclosure is easier than a later accidental discovery, and counsellors at ICTC are trained to help with how and when.

If disclosure is followed by abuse, threats, eviction from the marital home, denial of property or any form of coercion, this is domestic violence under the Protection of Women from Domestic Violence Act, 2005, regardless of the HIV trigger. For where to turn for legal help when health and abuse intersect, see accessing legal help for health abuse.

If a healthcare provider behaves dismissively, refuses care, or makes the woman feel she should not be pregnant at all, this is not normal or acceptable. ICTC counsellors and SACS officers can intervene and often help find a different provider; how to recognise and act when doctors don't listen is a useful wider read.

An HIV diagnosis around pregnancy in India in 2026 is, medically, a very different situation than it was twenty years ago. The medication is one tablet a day, it is free, and it does the job. The PMTCT pathway is well-established in the government system. Healthy pregnancies, healthy vaginal deliveries and HIV-negative babies are the norm now, not the exception, for women who get into care and stay in care.

What has not changed at the same pace is the social environment — the stigma, the silence, and the assumption that an HIV-positive woman should not be having children at all. None of that assumption is medical, and none of it reflects how PMTCT actually works. The legal protections exist on paper and are increasingly being used; the helplines exist and they answer; the counsellors exist and they are trained.

If you are reading this around a fresh diagnosis or a planned pregnancy, the practical sequence is simple — register at the nearest ICTC, start ART, attend the antenatal visits, get the viral load to undetectable before delivery, deliver in hospital, give the baby the nevirapine syrup and bring them back for the follow-up tests. Add to that the things any pregnancy needs — rest, nutrition, mental health support, a person you can talk to. The rest is the same pregnancy any other woman is having, with a clear, well-tested plan to keep both her and her baby safe.